Day: March 31, 2026

New Research Sheds Light on Why Atopic Dermatitis So Often Begins in Childhood

Photo by Chayene Rafaela on Unsplash

A team of researchers at the Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine, and other institutions have uncovered a key biological explanation for why atopic dermatitis (eczema) so often starts in childhood. The study, in young mice, found that some types of immune cells in early-life skin are more reactive than those in adults, a difference that may help explain why children are more vulnerable to inflammation and allergic skin disease. 

The findings, reported in Nature, suggest that early childhood represents a critical window for immune-driven skin disease and may shed light on why atopic dermatitis is often the first condition in a broader pattern of allergic disease.

Atopic dermatitis (AD) affects nearly one in four children and often appears early in life. It can also precede other allergic conditions, including asthma and food allergies. Until now, scientists have not fully understood why the disease is so strongly linked to early childhood. 

“We found that allergy risk is shaped very early in life, when the skin’s immune system is biologically programmed to overreact to allergens, with important consequences for understanding how immune-mediated diseases emerge and should be treated,” says senior study author Shruti Naik, PhD, Associate Professor of Immunology and Immunotherapy, and Dermatology at the Icahn School of Medicine. “By pinpointing the cells and hormonal signals that control this window of vulnerability, we open the door to strategies that could prevent allergic disease before it spreads from the skin to the lungs, gut, and beyond.”  

The researchers discovered that a specific immune cell type, the dendritic cell, in young skin behaves differently than in adults. These cells do not overreact to everything – but when it comes to allergens, they respond faster and more strongly, setting the stage for inflammation and AD early in life. In adult skin, the same cells are far less reactive.  

To understand why allergies often start in early childhood, researchers exposed infant mice to everyday allergens such as dust mites and mould. Unlike adult mice, the infants developed strong skin inflammation, revealing a brief early-life period when the skin’s immune system is especially sensitive.  

The scientists traced this response to dendritic cells, which are unusually active shortly after birth and triggers allergic inflammation. When this pathway was blocked, the young mice did not develop skin allergies.  

The team also found that infants lack normal levels of stress hormones that later help keep immune reactions in check, allowing these allergic responses to take hold. Importantly, signs of the same immune activity were found in skin samples from children with early-onset AD, but not in adults, suggesting this early-life window may also be important in humans. 

“This work was only possible through a true clinic-to-lab collaboration – where insights from paediatric patients shaped the questions we asked in the lab,” says study co-author Emma Guttman-Yassky, MD, PhD, professor at the Icahn School of Medicine. “By studying allergic disease where it actually begins, in early life, and by modelling clinically relevant allergens and disease features, lead author Yue Xing, PhD, uncovered immune biology that simply doesn’t appear in adult models. By revealing what’s unique about the early-life immune system, this work explains why eczema so often begins in infancy.” 

Next, the investigators plan to explore ways to block this early-life immune pathway to stop allergic disease before it spreads from the skin to other organs.  

“Beyond eczema, this study reinforces a critical point for medicine,” says Dr Naik. “Children are not simply small adults when it comes to immunity. Their immune system follows a unique set of rules, and recognising that difference is essential for understanding – and ultimately preventing – allergic, immune-driven diseases that begin in childhood.” 

Source: Mount Sinai

Burnout May Lead Family Doctors to Leave Medicine

Of the nearly 20 000 physicians in a study led by Weill Cornell researchers,43.5% reported feeling burned out.

Photo by Usman Yousaf on Unsplash

Family physicians who report feeling burned out are nearly 1.5 times more likely to change practices or stop practising medicine entirely compared to their peers who don’t report burnout, a study by Weill Cornell Medicine researchers found. Physician burnout can include emotional exhaustion, detachment from patients and colleagues, and feeling that work is no longer meaningful.

The findings, published March 30 in JAMA Internal Medicine, also highlight the consequences for patients: people who lose their family physician may be more likely to visit the emergency room, spend more on health care and be less satisfied with their care than those who keep their doctors.

“To our knowledge, this is the first national-level study examining the association between physician burnout and turnover,” said Dr Amelia Bond, associate professor of population health sciences at Weill Cornell Medicine, who co-led the study.

To quantify burnout, Dr. Bond and her colleagues turned to the 2016-2020 American Board of Family Medicine surveys, which family physicians must complete to obtain and maintain board certification. As part of the survey, physicians are asked whether they feel burned out or callous.

The researchers then determined whether physicians changed practices or stopped practising altogether in the subsequent year, based on billing patterns in de-identified Medicare data.

Of the nearly 20 000 physicians in the study, 43.5% reported burnout. Doctors under the age of 55 were more likely to report burnout than older doctors, and women were more likely to report burnout than men.

The research suggests that workplace stress may reduce physician retention. Among physicians who reported burnout, 4.8% changed practices versus 3.4% of physicians who did not report burnout; 5.4% of physicians with burnout stopped practising entirely compared to 3.7% of physicians without burnout.

“These findings highlight the urgent need to address work conditions and professional satisfaction for both the stability of the physician workforce and the well-being of patients,” said Dr Dhruv Khullar, associate professor of population health sciences at Weill Cornell Medicine and co-lead on the study. 

Physician burnout and turnover have clinical, organisational and economic implications. “The issue definitely warrants more attention,” D. Bond said.

Further investigation could identify practices, systems and policy factors that may reduce rates of physician burnout and turnover. While this study found a correlation, additional work will be needed to establish a causal link between burnout and turnover.

Source: Weill Cornell Medicine

Pain Neurons Protect Nerve Health and Offer New Therapeutic Targets

A healthy neuron. Credit: NIH

Researchers at Karolinska Institutet, have uncovered a previously unknown mechanism that helps pain sensing nerve cells stay healthy and respond to injury. The findings, published in Nature Communications, may improve understanding of chronic pain and nerve damage and maintenance of myelin integrity.

A new study shows that a molecule called RNase4, is produced by specialised pain-sensing neurons. It plays a key role in maintaining their normal function and influences both these neurons and the structure of nearby nerve fibres, positioning pain-sensing neurons not only as sensory transducers but also as sentinels of nerve integrity.

The researchers showed that RNase4 is expressed in unmyelinated sensory neurons, including neurons that innervate the auditory organ, and in the pain-sensing neurons that innervate the face, head, dura mater, and the rest of the body. By combining multiple experimental approaches on mice, they demonstrated that loss of RNase4 alters mechanical pain responses and disrupts the myelin structure surrounding neighbouring nerve fibres. They also found that RNase4 levels increase after nerve injury, both during the pain phase and the subsequent recovery period.

“Our results point to RNase4 as part of a regulatory pathway that supports nerve integrity. This molecule has not previously been linked to pain sensing neurons, so its presence and role came as a surprise,” says corresponding author Saida Hadjab, head of the Neurobiology of pain & Therapeutics laboratory at the Department of Neuroscience.

Chronic pain is often difficult to treat, partly because the underlying biology is still not fully understood. The findings suggest that pain sensing neurons may take on a more active role in maintaining the health of surrounding nerve tissue.

“This work has enabled us to identify a novel mechanism and position RNase4 as a regulator of afferent neuron integrity and local microenvironment. The localisation of RNase4 and its function in sensory neurons made it directly relevant to hearing dysfunction, headache, and chronic pain,” says Saida Hadjab.

RNase4 shows a comparable expression pattern in human pain-sensing neurons, supporting its potential relevance in humans. While further research is required to develop therapies targeting the RNase4 pathway, these findings provide a strong foundation for advancing the study of myelin integrity and long-lasting pain in humans.

Source: Karolinska Institutet

Screening Tests for Autism Miss Many Children at Risk

Photo by Helena Lopes on Unsplash

M-CHAT does not catch all children with autism in the neonatal high-risk group, shows a study from Karolinska Institutet published in JAMA Network Open. The researchers see a need to supplement the test with other assessment methods.

Children born very prematurely or with complications are screened at the age of two for early signs of autism using the M-CHAT questionnaire. In a new national study, researchers at Karolinska Institutet have investigated how well the test works in this high-risk group. The study includes 2178 children born in Sweden between 2013 and 2019 and compares M-CHAT results with later clinical diagnoses of autism.

The researchers found that the test was highly accurate in ruling out autism, but that many children with autism were still missed. The sensitivity was 62%, while the specificity – the ability to identify children without autism – was 91%. In total, 12% of the children received a positive M-CHAT result and 6% were later diagnosed with autism.

“The results show that M-CHAT works relatively well to rule out autism, but that it does not catch all children who later receive a diagnosis. In this high-risk group, more tools are therefore needed to detect children who need further investigation early,” says Ulrika Ådén, professor at the Department of Women’s and Children’s Health.

Children born extremely prematurely had both the highest proportion of positive test results and the most autism diagnoses. The researchers also saw that girls had fewer positive test results than boys, and that linguistic factors could affect the outcome – the test had higher specificity in families that spoke a Scandinavian language.

“Overall, the study shows that other developmental difficulties, such as motor or sensory problems, can affect how M-CHAT is interpreted. This needs to be taken into account when healthcare works with early screening,” says Ulrika Ådén.

Source: Karolinska Institutet